Your browser doesn't support javascript.
loading
Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability.
Ridgeon, Elliott; Bellomo, Rinaldo; Myburgh, John; Saxena, Manoj; Weatherall, Mark; Jahan, Rahi; Arawwawala, Dilshan; Bell, Stephanie; Butt, Warwick; Camsooksai, Julie; Carle, Coralie; Cheng, Andrew; Cirstea, Emanuel; Cohen, Jeremy; Cranshaw, Julius; Delaney, Anthony; Eastwood, Glenn; Eliott, Suzanne; Franke, Uwe; Gantner, Dashiell; Green, Cameron; Howard-Griffin, Richard; Inskip, Deborah; Litton, Edward; MacIsaac, Christopher; McCairn, Amanda; Mahambrey, Tushar; Moondi, Parvez; Newby, Lynette; O'Connor, Stephanie; Pegg, Claire; Pope, Alan; Reschreiter, Henrik; Richards, Brent; Robertson, Megan; Rodgers, Helen; Shehabi, Yahya; Smith, Ian; Smith, Julie; Smith, Neil; Tilsley, Anna; Whitehead, Christina; Willett, Emma; Wong, Katherine; Woodford, Claudia; Wright, Stephen; Young, Paul.
Afiliação
  • Ridgeon E; Medical Research Institute of New Zealand, Wellington, New Zealand. paul.young@ccdhb.org.nz.
  • Bellomo R; University of Melbourne, Melbourne, VIC, Australia.
  • Myburgh J; George Institute for Global Health, Sydney, NSW, Australia.
  • Saxena M; George Institute for Global Health, Sydney, NSW, Australia.
  • Weatherall M; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Jahan R; Intensive Care National Audit and Research Centre, London, United Kingdom.
  • Arawwawala D; Mid Essex Hospitals NHS Trust, Chelmsford, United Kingdom.
  • Bell S; Critical Care Unit, Ipswich Hospital NHS Trust, Ipswich, United Kingdom.
  • Butt W; Intensive Care Unit, Royal Children's Hospital, Melbourne, VIC, Australia.
  • Camsooksai J; Poole Hospital NHS Foundation Trust, Poole, United Kingdom.
  • Carle C; Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, United Kingdom.
  • Cheng A; St George Hospital, Sydney, NSW, Australia.
  • Cirstea E; South Tees NHS Trust, Middlesbrough, United Kingdom.
  • Cohen J; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Cranshaw J; Royal Bournemouth Hospital, Bournemouth, United Kingdom.
  • Delaney A; Australia and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
  • Eastwood G; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
  • Eliott S; Intensive Care Unit, Monash Medical Centre, Melbourne, VIC, Australia.
  • Franke U; South Tees NHS Trust, Middlesbrough, United Kingdom.
  • Gantner D; Australia and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
  • Green C; Department of Intensive Care Medicine, Frankston Hospital, Melbourne, VIC, Australia.
  • Howard-Griffin R; Critical Care Unit, Ipswich Hospital NHS Trust, Ipswich, United Kingdom.
  • Inskip D; St George Hospital, Sydney, NSW, Australia.
  • Litton E; Fiona Stanley Hospital, Perth, WA, Australia.
  • MacIsaac C; University of Melbourne, Melbourne, VIC, Australia.
  • McCairn A; Intensive Care Unit, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, United Kingdom.
  • Mahambrey T; Intensive Care Unit, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, United Kingdom.
  • Moondi P; Queen Elizabeth Hospital, Kings Lynn, United Kingdom.
  • Newby L; Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand.
  • O'Connor S; Intensive Care Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Pegg C; Medway NHS Foundation Trust, Gillingham, United Kingdom.
  • Pope A; Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, United Kingdom.
  • Reschreiter H; Poole Hospital NHS Foundation Trust, Poole, United Kingdom.
  • Richards B; Gold Coast Hospital and Health Service, Gold Coast, QLD, Australia.
  • Robertson M; St Vincent's Hospital, Melbourne, VIC, Australia.
  • Rodgers H; Canberra Hospital, Canberra, ACT, Australia.
  • Shehabi Y; Intensive Care Unit, Monash Medical Centre, Melbourne, VIC, Australia.
  • Smith I; Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom.
  • Smith J; Intensive Care Unit, Bendigo Hospital, Bendigo, VIC, Australia.
  • Smith N; Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom.
  • Tilsley A; Department of Intensive Care Medicine, Middlemore Hospital, Auckland, New Zealand.
  • Whitehead C; Westmead Hospital, Sydney, NSW, Australia.
  • Willett E; Royal Bournemouth Hospital, Bournemouth, United Kingdom.
  • Wong K; Queen Elizabeth Hospital, Kings Lynn, United Kingdom.
  • Woodford C; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Wright S; Freeman Hospital, Newcastle upon Tyne, United Kingdom.
  • Young P; Medical Research Institute of New Zealand, Wellington, New Zealand.
Crit Care Resusc ; 18(1): 50-4, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26947416
ABSTRACT

OBJECTIVE:

Trials in critical care have previously used unvalidated systems to classify cause of death. We aimed to provide initial validation of a method to classify cause of death in intensive care unit patients. DESIGN, SETTING AND

PARTICIPANTS:

One hundred case scenarios of patients who died in an ICU were presented online to raters, who were asked to select a proximate and an underlying cause of death for each, using the ICU Deaths Classification and Reason (ICU-DECLARE) system. We evaluated two methods of categorising proximate cause of death (designated Lists A and B) and one method of categorising underlying cause of death. Raters were ICU specialists and research coordinators from Australia, New Zealand and the United Kingdom. MAIN OUTCOME

MEASURES:

Inter-rater reliability, as measured by the Fleiss multirater kappa, and the median proportion of raters choosing the most likely diagnosis (defined as the most popular classification choice in each case).

RESULTS:

Across all raters and cases, for proximate cause of death List A, kappa was 0.54 (95% CI, 0.49-0.60), and for proximate cause of death List B, kappa was 0.58 (95% CI, 0.53-0.63). For the underlying cause of death, kappa was 0.48 (95% CI, 0.44-0.53). The median proportion of raters choosing the most likely diagnosis for proximate cause of death, List A, was 77.5% (interquartile range [IQR], 60.0%-93.8%), and the median proportion choosing the most likely diagnosis for proximate cause of death, List B, was 82.5% (IQR, 60.0%-92.5%). The median proportion choosing the most likely diagnosis for underlying cause was 65.0% (IQR, 50.0%-81.3%). Kappa and median agreement were similar between countries. ICU specialists showed higher kappa and median agreement than research coordinators.

CONCLUSIONS:

The ICU-DECLARE system allowed ICU doctors to classify the proximate cause of death of patients who died in the ICU with substantial reliability.
Assuntos
Buscar no Google
Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Causas de Morte / Cuidados Críticos Tipo de estudo: Etiology_studies Limite: Humans País/Região como assunto: Europa / Oceania Idioma: En Revista: Crit Care Resusc Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Nova Zelândia
Buscar no Google
Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Causas de Morte / Cuidados Críticos Tipo de estudo: Etiology_studies Limite: Humans País/Região como assunto: Europa / Oceania Idioma: En Revista: Crit Care Resusc Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Nova Zelândia